Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis

被引:0
作者
Mykén, P [1 ]
Bech-Hanssen, O
Phipps, B
Caidahl, K
机构
[1] Sahlgrens Univ Hosp, Dept Thorac & Cardiovasc Surg, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Clin Physiol, S-41345 Gothenburg, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of study: The study aim was to review the 15-year results of aortic (AVR) and mitral (MVR) valve replacement with the St. Jude Medical Biocor porcine prosthesis, in order to investigate long-term survival and valve-related complications. Methods: Between January 1983 and January 1998, a total of 1,187 patients underwent either AVR (n = 1,029; mean age 69 years) or MVR (n = 158; mean age 63 years). Follow up (99.7% complete) was monitored in 1998, and all data were analyzed with regard to actuarial valve failure rates. Long-term echocardiographic data were obtained. Results: Cumulative follow up time was 5,049 patient-years (pt-yr) for AVR patients, and 845 pt-yr for MVR patients. Actuarial survival rate at 15 years was 41 +/- 3%, and freedom from valve-related death was 94 +/- 1% for the AVR group; corresponding values for the MVR group were 25 +/- 11% and 84 +/- 6%. The occurrence of structural valve deterioration (SVD) varied with age; older patients were less affected. Freedom from SVD was 76 +/- 7% and 92 +/- 4% for AVR and MVR patients, respectively. Thromboembolism (TE) occurred mainly among the oldest patients, and was most prevalent among those with MVR. Actuarial freedom from TE was 82 +/- 5% after AVR and 75 +/- 7% after MVR. Prosthetic valve endocarditis (PVE) was rare, but caused the only reoperative mortality. Freedom from PVE was 95 +/- 2% after AVR and 93 +/- 3% after MVR. Conclusion: Although the optimal valve substitute remains to be found, this long-term study of a third-generation bioprosthesis showed a low incidence of valve-related complications, especially of valve deterioration. This type of bioprosthesis appears to be more durable than valves of previous generations.
引用
收藏
页码:415 / 422
页数:8
相关论文
共 24 条
  • [1] INFLUENCE OF FIXATION CONDITIONS ON THE PERFORMANCE OF GLUTARALDEHYDE-TREATED PORCINE AORTIC VALVES - TOWARDS A MORE SCIENTIFIC BASIS
    BROOM, ND
    THOMSON, FJ
    [J]. THORAX, 1979, 34 (02) : 166 - 176
  • [2] BURDON TA, 1992, J THORAC CARDIOV SUR, V103, P238
  • [3] Twenty-year follow-up of the Hancock modified orifice porcine aortic valve
    Cohn, LH
    Collins, JJ
    Rizzo, RJ
    Adams, DH
    Couper, GS
    Aranki, SF
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (06) : S30 - S34
  • [4] Guidelines for reporting morbidity and mortality after cardiac valvular operations
    Edmunds, LH
    Clark, RE
    Cohn, LH
    Grunkemeier, GL
    Miller, DC
    Weisel, RD
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (03) : 708 - 711
  • [5] FANN J, 1996, J THORAC CARDIOVASC, V8, P259
  • [6] Twenty-year clinical experience with porcine bioprostheses - Discussion
    Jamieson, WRE
    Fann, JI
    Replogle, RL
    [J]. ANNALS OF THORACIC SURGERY, 1996, 62 (05) : 1311 - 1312
  • [7] Frater RWM, 1998, J HEART VALVE DIS, V7, P48
  • [8] DETERMINANTS OF REOPERATION AFTER 960 VALVE REPLACEMENTS WITH CARPENTIER-EDWARDS PROSTHESES
    GLOWER, DD
    WHITE, WD
    HATTON, AC
    SMITH, LR
    YOUNG, WG
    WOLFE, WG
    LOWE, JE
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) : 381 - 393
  • [9] Determinants of 15-year outcome with 1,119 standard Carpentier-Edwards porcine valves
    Glower, DD
    Landolfo, KP
    Cheruvu, S
    Cen, YY
    Harrison, JK
    Bashore, TM
    Smith, PK
    Jones, RH
    Wolfe, WG
    Lowe, JE
    [J]. ANNALS OF THORACIC SURGERY, 1998, 66 (06) : S44 - S48
  • [10] PORCINE AORTIC-VALVE BIOPROSTHESES - A MORPHOLOGIC COMPARISON OF THE EFFECTS OF FIXATION PRESSURE
    HILBERT, SL
    BARRICK, MK
    FERRANS, VJ
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1990, 24 (06): : 773 - 787